The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Who Should Avoid It Cancer history or active malignancy Severe diabetes requiring tight glucose control Carpal tunnel syndrome or nerve compression disorders Stop Right Away If You Notice Persistent joint pain or swelling indicating fluid retention Significant blood glucose changes or diabetic control issues Unusual fatigue, lethargy, or mood deterioration Injection site infections or persistent reactions Numbness or tingling in hands/feet Signs of accelerated tumor growth if cancer history exists Milder Signs to Watch For How Long Should a CJC-1295/Ipamorelin Blend (CJC-1295 (without DAC), Ipamorelin) Cycle Last
Singh RK, Chang HW, Yan D, et al
Individual tolerance to GLP-1s varies but the most common side effects are nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat
